We are in the midst of a major revolution in medicine that
is changing the paradigm for health care. The explosions in
human genetics and the rapid progress toward the goal of
sequencing the human genome will open up unparalleled frontiers
for understanding the cellular and molecular changes underlying
disease, and with it will come new targets for therapy.
The current paradigm for treatment of disease is to see a patient when he or she
manifests with signs and symptoms and then to institute appropriate diagnosis
and therapy. New advances in genetic medicine will allow the earlier description
of the patterns of gene expression which underlie the natural history and
process of cellular dysfunction, leading to injury, prior to patients presenting
with signs and symptoms. Thus, diseases will be diagnosed much earlier and this
will allow preventive therapies to be undertaken to halt the progression of the
illness or to slow down its course.
Prior to studying patterns
of disease in humans, the best way to define the natural history of an illness
is to look at its cellular and molecular characteristics in animal models such
as in transgenic mice. These models provide unique insights into the cellular
mechanisms underlying disease and this information can be rapidly transferred to
human diseases with the accompanying improvement in understanding and more
rational approach to therapies.
Medical research will be defined as that
which was performed before the Human Genome Project and that which occurred
after. The field of human molecular genetics is in its earliest stages of
development and will reach maturity in the next century. Just as physics
heralded the technological advances in the 20th century, so human
genetics will be the catalyst for new insights into disease and new approaches
to therapy in the 21st century. Using these approaches, diseases for
which there is currently no rational approach to therapy will be addressed with
new approaches based on the insights into the fundamental mechanisms in these
diseases. This will lead to new therapies focused directly on the disease
mechanism, and is likely to lead to therapies which are more effective and
associated with fewer side effects.
This is indeed a very exciting
time for scientists in this field and for patients suffering from many incurable
illnesses who await these discoveries with much hope and also with trepidation.